Trial intelligence / Profile preview

DHEA Supplementation Pre-IVF in DOR Patients

NCT02866253Phase 4Completed

Sponsor
Shanghai Ji Ai Genetics & IVF Institute
Start
Dec 2014
Primary completion
Dec 2015
Modality
Allosteric Modulators
01

Overview

A Phase 4 trial of dehydroepiandrosterone in Diminished Ovarian Reserve (DOR), sponsored by Shanghai Ji Ai Genetics & IVF Institute. Started Dec 2014; status: completed.

02

Drugs

dehydroepiandrosterone
03

Conditions

Diminished Ovarian Reserve (DOR)

Beyond the preview

Go deeper on NCT02866253.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT02866253.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call